In light of our results, it is tempting to speculate that modulation the PDPN/CLEC-2/CD177 axis may represent an alternative approach to remove obstacles for T cell entry into tumor beds, by lessening CAF contractility and ultimately decreasing tissue stiffness. This evidence concerns the gene CLEC1B and neoplasm.